Ignite Creation Date:
2024-10-26 @ 3:42 PM
Last Modification Date:
2024-10-26 @ 3:42 PM
Study NCT ID:
NCT06636695
Status:
COMPLETED
Last Update Posted:
None
First Post:
2024-10-08
Brief Title:
Clinical Efficacy of Platelet-Rich Plasma and Hyaluronic Acid Versus Hyaluronic Acid for Knee Osteoarthritis with MRI Analysis
Sponsor:
None
Organization:
None
Study Overview
Official Title:
Clinical Efficacy of Platelet-Rich Plasma and Hyaluronic Acid Versus Hyaluronic Acid for Knee Osteoarthritis with MRI Analysis a Randomized Controlled Trial
Status:
COMPLETED
Status Verified Date:
2024-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The study hypothesizes that the combination of Cellular Matrix PRP-HA is superior to Hyaluronic Acid HA alone specifically from the Orthovisc Kit in relieving pain and function associated with knee osteoarthritis
The primary objective is to assess pain reduction following treatment The secondary objectives includes assessing the treatments impact on function stiffness and overall quality of life for patients In addition non-invasive MRI will be employed at baseline and 12 months to evaluate changes in bone marrow edema cartilage structure and joint effusion The study also aims to compare the safety of Cellular Matrix PRP-HA and HA
The primary objective is to assess pain reduction following treatment The secondary objectives includes assessing the treatments impact on function stiffness and overall quality of life for patients In addition non-invasive MRI will be employed at baseline and 12 months to evaluate changes in bone marrow edema cartilage structure and joint effusion The study also aims to compare the safety of Cellular Matrix PRP-HA and HA
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None